IP Library Granted Patent US 12,529,049
Granted Patent B2
US 12,529,049 · App. 17/929,420 · Granted Jan 20, 2026

Characterization and localization of protein modifications

Inventors: James Henry Joly (San Mateo, CA); Torri Elise Rinker (San Francisco, CA); Christina E. Inman (San Mateo, CA)
Assignee: NAUTILUS SUBSIDIARY, INC.
C12N15/1065C40B20/02C40B20/04C40B70/00G01N33/6842G01N2440/14G01N2458/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,529,049
App. No.
17/929,420
Granted
Jan 20, 2026
Kind
B2
Abstract

A method for characterizing proteins, including steps of (a) detecting a plurality of proteins, wherein individual proteins of the plurality are associated with unique identifiers, wherein the detecting distinguishes the identities of the individual proteins and the unique identifiers associated with the individual proteins; (b) digesting the proteins to form peptides, wherein the peptides from each protein are associated with the unique identifiers for the respective individual protein; (c) detecting the peptides and associated unique identifiers, wherein the detecting distinguishes characteristics of individual peptides, and wherein the detecting distinguishes unique identifiers associated with the individual peptides; and (d) correlating characteristics detected in step (c) with individual proteins detected in step (a) based on the unique identifiers associated with the individual proteins and the peptides.

Claims (29)

1 . A composition, comprising:

a) a nucleic acid particle; and

b) a polypeptide attached to the nucleic acid particle through two or more linking moieties,

wherein first ends of the two or more linking moieties are attached to the nucleic acid particle and second ends of the two or more linking moieties are attached to the polypeptide.

2 . The composition of claim 1 , wherein the polypeptide comprises a full-length protein.

3 . The composition of claim 1 , wherein the composition comprises a plurality of polypeptides, and each polypeptide in the plurality of polypeptides is attached to two or more linking moieties.

4 . The composition of claim 1 , wherein each of the two or more linking moieties comprises a same identifier label.

5 . The composition of claim 1 , wherein the polypeptide is attached to a linking moiety of the two or more linking moieties by a bond between the polypeptide and an identifier label attached to the linking moiety.

6 . The composition of claim 1 , wherein the polypeptide comprises at least one cleavage site.

7 . The composition of claim 6 , wherein the cleavage site is located on the polypeptide between an attachment site of a first linking moiety of the two or more linking moieties and a second attachment site of a second linking moiety of the two or more linking moieties.

8 . The composition of claim 1 , wherein the polypeptide comprises a post-translational modification.

9 . The composition of claim 8 , wherein the composition comprises a plurality of polypeptides and a second polypeptide in the composition does not comprise the post-translational modification.

10 . The composition of claim 1 , further comprising a solid support.

11 . The composition of claim 10 , wherein the nucleic acid particle is attached to the solid support.

12 . The composition of claim 11 , wherein the nucleic acid particle is contained within a well of the solid support.

13 . The composition of claim 12 , wherein the nucleic acid particle is attached to a bead, and wherein the bead is contained in the well of the solid support.

14 . The composition of claim 1 , further comprising an affinity reagent bound to the polypeptide.

15 . The composition of claim 14 , wherein the affinity reagent is bound to a post-translational modification of the polypeptide.

16 . The composition of claim 14 , wherein the affinity reagent is bound to a trimer, tetramer, pentamer, or hexamer epitope of the polypeptide.

17 . The composition of claim 1 , wherein the polypeptide further comprises a molecular barcode.

18 . An array comprising a first address for binding a first polypeptide and a second address for binding a second polypeptide, wherein the first address and the second address are optically resolvable, wherein the first address is attached to a first nucleic acid particle, wherein the second address is attached to a second nucleic acid particle, and wherein:

a) the first nucleic acid particle comprises two or more linking moieties, wherein the two or more linking moieties of the first nucleic acid particle are attached to the first polypeptide; and

b) the second nucleic acid particle comprises two or more linking moieties, wherein the two or more linking moieties of the second nucleic acid particle are attached to the second polypeptide;

wherein the first polypeptide differs from the second polypeptide.

19 . A system comprising:

a) a solid support, wherein an address of the solid support is attached to a nucleic acid particle, wherein the particle comprises two or more linking moieties, wherein the two or more linking moieties of the nucleic acid particle are attached to a polypeptide;

b) a detectable affinity reagent, wherein the detectable affinity reagent is configured to provide a detectable signal, and wherein the detectable affinity reagent is configured to be delivered to the solid support;

c) an optical detector; and

d) one or more processors programmed to read data from the optical detector to detect a presence or absence of the detectable signal at the address of the solid support.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 28, 2024
From: JOLY, JAMES HENRY; RINKER, TORRI ELISE; INMAN, CHRISTINA E.
To: NAUTILUS BIOTECHNOLOGY, INC.
Reel/Frame 066939/0719 →
CHANGE OF NAME Recorded Apr 13, 2023
From: NAUTILUS BIOTECHNOLOGY, INC.
To: NAUTILUS SUBSIDIARY, INC.
Reel/Frame 063325/0533 →
Continuity (2)
Provisional Application 63242433 · Sep 9, 2021
Related Publication 20230070896A1 · Mar 9, 2023
References Cited (62)
US 7306904B2 · Landegren et al. · 2007 [cited by applicant]
US 7351528B2 · Landegren · 2008 [cited by applicant]
US 7569129B2 · Pamula et al. · 2009 [cited by applicant]
US 7901947B2 · Pollack et al. · 2011 [cited by applicant]
US 8013134B2 · Fredriksson · 2011 [cited by applicant]
US 8268554B2 · Schallmeiner · 2012 [cited by applicant]
US 8445194B2 · Drmanac et al. · 2013 [cited by applicant]
US 8501923B2 · Rothemund · 2013 [cited by applicant]
US 9340416B2 · Maune et al. · 2016 [cited by applicant]
US 9777315B2 · Fredriksson et al. · 2017 [cited by applicant]
US 9796749B2 · Yin et al. · 2017 [cited by applicant]
US 10227648B2 · Hindson et al. · 2019 [cited by applicant]
US 10473654B1 · Mallick · 2019 [cited by applicant]
US 10809254B2 · Pamula et al. · 2020 [cited by applicant]
US 11125748B2 · Gopinath et al. · 2021 [cited by applicant]
US 11162192B2 · Gopinath et al. · 2021 [cited by applicant]
US 11203612B2 · Gremyachinskiy et al. · 2021 [cited by applicant]
US 11214795B2 · Gopinath et al. · 2022 [cited by applicant]
US 11282585B2 · Patel et al. · 2022 [cited by applicant]
US 11391734B2 · Gopinath et al. · 2022 [cited by applicant]
US 11505796B2 · Aksel et al. · 2022 [cited by applicant]
US 20120211084A1 · Weitz et al. · 2012 [cited by applicant]
US 20160102344A1 · Niemeyer et al. · 2016 [cited by applicant]
US 20190145982A1 · Chee et al. · 2019 [cited by applicant]
US 20200082914A1 · Patel et al. · 2020 [cited by applicant]
US 20200318101A1 · Mallick et al. · 2020 [cited by applicant]
US 20200348307A1 · Beierle et al. · 2020 [cited by applicant]
US 20200348308A1 · Chee et al. · 2020 [cited by applicant]
US 20210101930A1 · Gremyachinskiy et al. · 2021 [cited by applicant]
US 20210132076A1 · Marcotte et al. · 2021 [cited by applicant]
US 20210148922A1 · Dyer et al. · 2021 [cited by applicant]
US 20210230587A1 · Gerling et al. · 2021 [cited by applicant]
US 20210239705A1 · Mallick · 2021 [cited by applicant]
US 20210254047A1 · Chee et al. · 2021 [cited by applicant]
US 20210390705A1 · Egertson et al. · 2021 [cited by applicant]
US 20220162684A1 · Aksel et al. · 2022 [cited by applicant]
US 20220227890A1 · Kapp et al. · 2022 [cited by applicant]
US 20220236282A1 · Mallick et al. · 2022 [cited by applicant]
US 20220339181A1 · Funke et al. · 2022 [cited by applicant]
WO WO2012044612A1 · 2012 [cited by examiner]
WO WO2018102759A1 · 2018 [cited by examiner]
WO WO2019195633 · 2019 [cited by applicant]
WO WO2020106889 · 2020 [cited by applicant]
WO WO2020223368 · 2020 [cited by applicant]
WO WO2021087402 · 2021 [cited by applicant]
WO WO2022136573 · 2022 [cited by applicant]
WO WO2022218994 · 2022 [cited by applicant]
WO WO2022223802 · 2022 [cited by applicant]
WO WO2023038859 · 2023 [cited by applicant]
Aebersold et al., “How many human proteoforms are there?”, Nat Chem Biol vol. 14:206-214 (2018). [cited by applicant]
Alfaro et al., “The emerging landscape of single-molecule protein sequencing technologies”, Nature Publishing Group US, vol. 18(6):604-617 (2021). [cited by applicant]
Anderson et al., “The human plasma proteome: history, character, and diagnostic prospetcs”, Molecular &Cellular Proteomics: MCP, vol. 1(11):845-867 (2002). [cited by applicant]
Bransky et al, “A microfluidic droplet generator based on a piezolectri cactuator”, The Royal Society of Chemistry, vol. 9:516-520 (2009). [cited by applicant]
Demirci et al., “Single cell epitaxy by acoustic picolitre droplets”, Lab Chip, vol. 7:1139-1145 (2007). [cited by applicant]
Egertson et al., “A theoretical framework for proteome-scale single-molecule protein identification using multi-affinity protein binding reagents”, BioRxiv (2021), DOI: 10.1101/2021.10-11.463967. [cited by applicant]
Nguyen et al., “Developing bioorthogonal probes to span a spectrum of reactivities”, Nat Rev Chem, vol. 4:476-489 (2020). [cited by applicant]
Patterson et al., “Orthogonal bioorthogonal chemistries”, Current Opinion in Chemical Biology, vol. 28:141-149 (2015). [cited by applicant]
Rothemund et al., “Folding DNA to create nanoscale shapes and patterns”, Nature, vol. 440(7082):297-302 (2006). [cited by applicant]
Sigl et al., “Programmable icosahedral shell system for virus trapping”, Nat Mater, vol. 20(9):1281-1289 (2021). [cited by applicant]
Smith et al., “Proteoform: a single term describing protein complexity”, Nature Methods vol. 10(3):186-187 (2013). [cited by applicant]
Williams et al., “Amplification of complex gene libraries by emulsion PCR”, Nature Methods, vol. 3(7):545-550 (2006). [cited by applicant]
Zhao et al., “Organizing DNA origami tiles into larger structure suing pre-formed scaffold frames”, Nno Lett. vol. 11(7):2997-3002 (2011). [cited by applicant]